¿Cómo funciona la nueva prueba de anticuerpos de Covid-19?
May 18, 2020 - La farmacéutica suiza Roche lanzó su nueva prueba de anticuerpos de SARS-CoV-2. Conocida como Elecsys Anti-SARS-CoV-2, la prueba determina con 99,8% de precisión si una persona pudo haber obtenido inmunidad contra el virus.
The test involves taking a small sample of blood and testing it for antibodies which will indicate exposure to coronavirus disease (Covid-19). It is run on a Roche-manufactured platform (cobas e analyser) that is widely available in hospitals and laboratories around the world. A single test takes approximately 18 minutes.
Public Health England has approved the test, following the lead of the European Union and United States which have already given it preliminary approval, Reuters said.
Mass antibody testing with millions of kits is being considered by many countries as a way to speed the reopening of economies devastated by lockdowns and to introduce more tailored social distancing measures.
The antibody tests – also known as a serology test – show who has been infected, although it is not yet clear whether the presence of antibodies to the new coronavirus confers permanent immunity.
Graphic News Standards